Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI

• Published in: Frontiers in oncology Vol. 12; p. 937345
• Main Authors: Cai, Xiaomin, Chen, Zheng, Chang, Bowen, Tu, Ming, Li, Shiting, Wang, Xuhui, Chen, Ming
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 08-08-2022
• Subjects: BRAF; Glioblastoma multiforme; MRI; Nomogram; Oncology; Ring enhancement
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2022.937345

Background
Ring enhancement on magnetic resonance imaging (MRI) is an important characteristic of GBM. Though patients suffering from glioblastoma multiforme (GBM) with BRAF mutation (MUT BRAF) in V600E benefit from BRAF-targeted inhibitors, the relationship between ring enhancement and MUT BRAF remains elusive. The purpose of this study was to investigate the relationship between BRAF mutation status and the appearance of ring enhancement so as to guide preoperative targeted therapy for MUT BRAF GBM.
Methods
Patient’s population, clinical data and characteristic ring enhancement appearances on MRI were compared between GBM with MUT BRAF and GBM with WT BRAF. A receiver operating characteristic (ROC) curve analysis was performed to evaluate the differential diagnostic significance. A nomogram was developed to predict the mutation status of BRAF. Moreover, all the variables were re-analyzed between epithelioid GBM (E-GBM) with or without MUT BRAF.
Results
Compared to GBM with WT BRAF, GBM with MUT BRAF had specific ring enhancement appearances with multiple rings, multiple located lobes, regular shape of ring, uniform thickness of ring and smaller diameter of ring. Area under the curve (AUC) of all the variables’ combination was 0.929. The nomogram was developed and validated. The re-analyzed results between E-GBM with or without MUT BRAF were similar to these above. AUC of the combination of quantity of ring, quantity of located lobe and shape of ring was 0.962.
Conclusion
The characteristic ring enhancement appearances of GBM may play an important role in predicting BRAF mutation status preoperatively, especially in E-GBM. Further study with larger cases may provide more evidences to guide the pretreatment of targeted medicine for GBM patients with MUT BRAF in future.